Herbert Michael Pinedo
Affiliations: | VU University Medical Center, Amsterdam, Netherlands |
Google:
"Herbert Michael Pinedo" OR "Herbert M Pinedo"Bio:
https://www.researchgate.net/profile/Herbert_Pinedo
Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Jaap de Graeff | grad student | 1972 | Leiden | |
| (Renovasculaire hypertensie: een retrospektief ondezoek bij 167 patienten) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| van den Eertwegh AJ, Versluis J, van den Berg HP, et al. (2012) Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial. The Lancet. Oncology. 13: 509-17 |
| de Weger VA, Turksma AW, Voorham QJ, et al. (2012) Clinical effects of adjuvant active specific immunotherapy differ between patients with microsatellite-stable and microsatellite-instable colon cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 882-9 |
| Fontijn D, Adema AD, Bhakat KK, et al. (2007) O6-methylguanine-DNA-methyltransferase promoter demethylation is involved in basic fibroblast growth factor induced resistance against temozolomide in human melanoma cells. Molecular Cancer Therapeutics. 6: 2807-2815 |
| Hanna MG, Hoover HC, Pinedo HM, et al. (2006) Active specific immunotherapy with autologous tumor cell vaccines for stage II colon cancer: Logistics, efficacy, safety and immunological pharmacodynamics Human Vaccines. 2: 185-191 |
| Haanen JBAG, Baars A, Gomez R, et al. (2006) Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients Cancer Immunology, Immunotherapy. 55: 451-458 |
| Peters GJ, Moorsel CJAV, Lakerveld B, et al. (2006) Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines. International Journal of Oncology. 28: 237-244 |
| Hansma AHG, Broxterman HJ, Horst Ivd, et al. (2005) Recombinant human endostatin administered as a 28-day continuous intravenous infusion, followed by daily subcutaneous injections: a phase I and pharmacokinetic study in patients with advanced cancer Annals of Oncology. 16: 1695-1701 |
| Middelburg R, de Haas RR, Dekker H, et al. (2005) Induction of p53 up-regulated modulator of apoptosis messenger RNA by chemotherapeutic treatment of locally advanced breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 1863-9 |
| Uyl-de Groot CA, Vermorken JB, Hanna MG, et al. (2005) Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: A prospective study of medical and economic benefits Vaccine. 23: 2379-2387 |
| Bruin Md, Capel Tv, Smid K, et al. (2004) Role of Platelet Derived Endothelial Cell Growth Factor/Thymidine Phosphorylase in Fluoropyrimidine Sensitivity and Potential Role of Deoxyribose‐1‐Phosphate Nucleosides, Nucleotides & Nucleic Acids. 23: 1485-1490 |